Brief: Consun Pharmaceutical Says Unit Entered Agreement With Chengdu Brilliant Pharmaceutical
July 23 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* ON 28 JUNE, UNIT ENTERED STRATEGIC COOPERATION AGREEMENT
WITH
CHENGDU BRILLIANT PHARMACEUTICAL
* DEAL FOR COOPERATION IN FIELD OF CONTRAST MEDIUM
* UNIT ENTERED TRIPARTITE COOPERATION WITH BRILLIANT
PHARMACEUTICAL FOR PROJECT REGARDING A CERTAIN TYPE OF IODINE
PREPARATIONS
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director